Early research (Phase 1)Study completedNCT02185690
What this trial is testing
A Phase I/Ib Study of MEK162, a MEK Inhibitor, in Combination With Carboplatin and Pemetrexed in Patients With Non-squamous Carcinoma of the Lung
Who this might be right for
Lungcancer
University Health Network, Toronto 13